Page last updated: 2024-08-22

angiotensin ii and Coronary Artery Disease

angiotensin ii has been researched along with Coronary Artery Disease in 58 studies

Research

Studies (58)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	11 (18.97)	18.2507
2000's	34 (58.62)	29.6817
2010's	11 (18.97)	24.3611
2020's	2 (3.45)	2.80

Authors

Authors	Studies
Ferrara, F; La Porta, R; Trama, U; Troiano, V; Vitiello, A	1
Boylston, J; Casin, KM; Fillmore, N; Kohr, MJ; Liu, C; Ma, H; Murphy, E; Noguchi, A; Sinha, P; Sun, J; Wang, N; Zhou, G	1
Chen, J; Liu, SJ; Liu, SM; Liu, WH; Shi, J; Wang, L; Zhong, Y	1
Buszman, E; Jasik, K; Rzepecka-Stojko, A; Stojko, J	1
Abraham, D; Acar, E; Costantino, S; Gonçalves, IF; Hallström, S; Hamza, O; Kiss, A; Klein, KU; Paneni, F; Podesser, BK; Szabo, PL; Tretter, EV; Trojanek, S	1
Miura, S; Saku, K	1
An, FH; Chen, ZH; Gu, Y; Guo, CY; Jia, EZ; Kong, XQ; Li, CJ; Li, LH; Li, ZY; Liu, Z; Ma, WZ; Wang, LS; Yang, ZJ; Zhu, TB	1
Chen, Y; Chen, YE; Fan, J; Kang, D; Li, S; Liu, E; Niimi, M; Ning, B; Shiomi, M; Wang, YN; Wang, Z; Waqar, AB; Yu, Q; Zhang, J	1
Chen, W; Hao, P; Li, H; Li, J; Li, W; Meng, X; Yang, J; Zhang, C; Zhang, Y	1
Bie, P; Hansen, PBL; Jensen, BL; Johansen, SH; Lindholt, JS; Rasmussen, LM; Stubbe, J; Urbonavicius, S; Wintmo, P	1
Allen, CL; Bayraktutan, U	1
Adamzik, M; Baba, HA; Bitzer, K; Frey, UH; Heusch, G; Jakob, H; Peters, J; Schmieder, RE; Schneider, MP; Siffert, W	1
Lakatta, EG; Najjar, SS; Wang, M	1
Ceconi, C; Ferrari, R; Guardigli, G	1
Anastasia, L; Anversa, P; Cabral-Da-Silva, MC; Cappetta, D; D'Alessandro, DA; D'Amario, D; Ferreira-Martins, J; Fiorini, C; Goichberg, P; Hosoda, T; Kajstura, J; Leri, A; Michler, RE; Piccoli, M; Rota, M; Sanada, F; Steadman, E; Zheng, H	1
Arfa, O; Czech, T; Ebrahimian, T; Endtmann, C; Fritz, M; Laufs, U; Nickenig, G; Petoumenos, V; Wassmann, K; Wassmann, S; Werner, N	1
Caulfield, MT; McDonald, TO; O'Brien, KD; Olin-Lewis, K; Otto, CM; Probstfield, JL; Shavelle, DM	1
Holtz, J; Morawietz, H; Quinn, MT; Rueckschloss, U	1
Al-Fakhri, N; Gardemann, A; Hehrlein, FW; Heidt, M; Katz, N; Linhart, RE; Philipp, M	1
Ciećwierz, D; Dubaniewicz, W; Gruchala, M; Grzybowski, A; Koprowski, A; Limon, J; Ochman, K; Romanowski, P; Rynkiewicz, A; Sobiczewski, W; Targoński, R; Wasag, B; Wojtowicz, A	1
Mehta, JL; Singh, BM	1
Cox, CD; Tsikouris, JP	1
Adler, GK; Jonasson, L; Martinez-Vasquez, D; Mukasa, K; Oestreicher, EM; Roubsanthisuk, W; Stone, JR	1
Amano, M; Higashi, M; Hiroki, J; Ichiki, T; Kaibuchi, K; Kandabashi, T; Kawamura, N; Kubota, T; Morikawa, K; Shimokawa, H; Takeshita, A	1
Aubert, JF; Bouzourene, K; Brunner, HR; Duchosal, MA; Gabbiani, G; Hao, H; Hayoz, D; Korber, M; Mazzolai, L; Nussberger, J; Vallet, V	1
Mehta, JL	1
Hu, Z; Huang, XP; Lu, F; Mao, YL; Tan, G; Yuan, ZK	1
Böhm, M; Buikema, H; Nickenig, G; van der Harst, P; van Gilst, WH; Volbeda, M; Voors, AA; Wassmann, S	1
Gómez-Fernández, P	1
Bandlow, N; Bavendiek, U; Bley, S; Drexler, H; Grote, K; Grothusen, C; Haverich, A; Luchtefeld, M; Schieffer, B; Selle, T; Strüber, M	1
Sada, M	1
Adams, V; Erbs, S; Gielen, S; Gummert, JF; Hambrecht, R; Kränkel, N; Linke, A; Möbius-Winkler, S; Mohr, FW; Schuler, G	1
Standridge, JB	1
Kim, MP; Wahl, LM; Zhou, M	1
Imaizumi, T; Jinnouchi, Y; Matsui, T; Nakamura, K; Nakamura, Y; Takenaka, K; Yamagishi, S	1
Boonstra, PW; Buikema, H; Morshuis, WJ; Nickenig, G; Plokker, HW; Six, AJ; van der Harst, P; van Gilst, WH; van Veldhuisen, DJ; Voors, AA; Wagenaar, LJ; Wassmann, S	1
Channon, KM; Guzik, B; Guzik, TJ; Harrison, DG; Jopek, A; Kapelak, B; Korbut, R; Przybylowski, P; Sadowski, J; Wierzbicki, K	1
Fuster, V; Levy, AP; Moreno, PR; Purushothaman, KR; Sirol, M	1
Matsubara, H	1
Buikema, H; Morshuis, WJ; Nickenig, G; Plokker, HW; van de Wal, RM; van der Harst, P; van Gilst, WH; van Veldhuisen, DJ; Voors, AA; Wagenaar, LJ; Wassmann, S	1
Pitt, B; Timmis, AD	1
Chappell, MC; Ferrario, CM	1
Berry, GJ; Diet, F; Dzau, VJ; Gibbons, GH; Momose, N; Pratt, RE	1
Curzen, NP; Fox, KM	1
Gibbons, GH	1
Komatsu, R; Ueda, M	1
Pratt, RE	1
Hojo, Y; Ikeda, U; Shimada, K	2
Lerman, LO; Ritman, EL; Rumberger, JA; Schmermund, A	1
Higaki, J; Kojima, A; Naruko, T; Ogihara, T; Ohishi, M; Okamura, A; Rakugi, H; Ueda, M	1
Duerrschmidt, N; Galle, J; Hakim, K; Holtz, J; Morawietz, H; Niemann, B; Rueckschloss, U; Sawamura, T; Zerkowski, HR	1
Drexler, H; Harringer, W; Hilfiker, A; Hilfiker-Kleiner, D; Kaartinen, M; Kovanen, PT; Nussberger, J; Schieffer, B; Schieffer, E	1
Mancia, G; Morganti, A; Perondi, R; Pomidossi, G; Saino, A; Turolo, L	1
Bokemeyer, D; Kramer, HJ; Schmitz, U	1
Dell'Italia, LJ; Lucchesi, PA; Rocic, P	1
Levi, M; Moons, AH; Peters, RJ	1
Li, D; Mehta, JL	1

Reviews

18 review(s) available for angiotensin ii and Coronary Artery Disease

Article	Year
Recent progress in the treatment of cardiovascular disease using olmesartan. Clinical and experimental hypertension (New York, N.Y. : 1993), 2014, Volume: 36, Issue:7 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Coronary Artery Disease; Coronary Stenosis; Disease Models, Animal; Humans; Hypertension; Imidazoles; Plaque, Atherosclerotic; Tetrazoles	2014
Arterial aging and subclinical arterial disease are fundamentally intertwined at macroscopic and molecular levels. The Medical clinics of North America, 2009, Volume: 93, Issue:3 Topics: Age Factors; Aged; Aged, 80 and over; Aging; Angiotensin II; Animals; Coronary Artery Disease; Coronary Vessels; Endothelium, Vascular; Female; Humans; Hypertension; Male; Risk Factors	2009
Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium. Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:4 Topics: Acute Coronary Syndrome; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Atherosclerosis; Bradykinin; Cardiotonic Agents; Coronary Artery Disease; Disease Progression; Endothelial Cells; Endothelium, Vascular; Heart Failure; Humans; Hypertension; Peptidyl-Dipeptidase A; Perindopril; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic; Secondary Prevention; Stem Cells	2010
Interactions between the renin-angiotensin system and dyslipidemia: relevance in the therapy of hypertension and coronary heart disease. Archives of internal medicine, 2003, Jun-09, Volume: 163, Issue:11 Topics: Angiotensin II; Animals; Cholesterol; Coronary Artery Disease; Endothelium, Vascular; Humans; Hyperlipidemias; Hypertension; Lipoproteins, LDL; Oxidation-Reduction; Reactive Oxygen Species; Renin-Angiotensin System	2003
Pharmacologic blockade of the renin-angiotensin system: vascular benefits beyond commonly understood pharmacologic actions. Pharmacotherapy, 2003, Volume: 23, Issue:9 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Humans; Renin-Angiotensin System	2003
The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis. The Canadian journal of cardiology, 2004, Volume: 20 Suppl B Topics: Angiotensin II; Atherosclerosis; Biomarkers; Coronary Artery Disease; Diabetes Mellitus; Endothelial Cells; Gene Expression Regulation; Humans; Hypertension; Lipoproteins, LDL; Myocardial Ischemia; Oxidative Stress; Predictive Value of Tests; Receptors, Oxidized LDL; Risk Factors; Scavenger Receptors, Class E; Sensitivity and Specificity; Severity of Illness Index; Signal Transduction	2004
[Modulation of renin-angiotensin system for vascular protection in hypertensive patients and in patients with diabetic nephropathy]. Revista clinica espanola, 2004, Volume: 204, Issue:11 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Coronary Artery Disease; Diabetic Nephropathies; Humans; Hypertension; Renin	2004
Hypertension and atherosclerosis: clinical implications from the ALLHAT Trial. Current atherosclerosis reports, 2005, Volume: 7, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Blood Pressure; Coronary Artery Disease; Diuretics; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypertension; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Sodium Chloride Symporter Inhibitors; Sulfonamides; Survival Rate; Treatment Failure	2005
Neovascularization in human atherosclerosis. Circulation, 2006, May-09, Volume: 113, Issue:18 Topics: Angiotensin II; Animals; Aryl Hydrocarbon Receptor Nuclear Translocator; Atherosclerosis; Blood Proteins; Capillary Permeability; Cell Hypoxia; Chemotaxis, Leukocyte; Coronary Artery Disease; Coronary Vessels; Diagnostic Imaging; Disease Progression; Hemorrhage; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Macrophage Activation; Membrane Lipids; Models, Animal; Neovascularization, Physiologic; Oxidative Stress; Sus scrofa; Sympathetic Nervous System; Tunica Intima; Vasa Vasorum; Vascular Endothelial Growth Factor A	2006
Effects of ACE inhibitors on coronary atherosclerosis and restenosis. British heart journal, 1994, Volume: 72, Issue:3 Suppl Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; Humans; Hypertrophy, Left Ventricular; Recurrence; Renin-Angiotensin System; Ventricular Dysfunction, Left	1994
A new myocardial conversion of angiotensin I. Current opinion in cardiology, 1994, Volume: 9, Issue:5 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Chymases; Coronary Artery Disease; Heart Failure; Humans; Hypertension; Myocardium; Renin-Angiotensin System; Serine Endopeptidases	1994
Do ACE inhibitors modulate atherosclerosis? European heart journal, 1997, Volume: 18, Issue:10 Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cell Division; Coronary Artery Disease; Heart Failure; Humans; Muscle, Smooth, Vascular; Secondary Prevention	1997
Vasculoprotective and cardioprotective mechanisms of angiotensin-converting enzyme inhibition: the homeostatic balance between angiotensin II and nitric oxide. Clinical cardiology, 1997, Volume: 20, Issue:11 Suppl 2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Coronary Artery Disease; Hemodynamics; Homeostasis; Humans; Hypertension; Nitric Oxide	1997
[Plaque progression and destabilization in human coronary arteries]. Nihon rinsho. Japanese journal of clinical medicine, 1998, Volume: 56, Issue:10 Topics: Acute Disease; Angiotensin II; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Endothelial Growth Factors; Humans; Lymphokines; Peptidyl-Dipeptidase A; Syndrome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	1998
Angiotensin II and the control of cardiovascular structure. Journal of the American Society of Nephrology : JASN, 1999, Volume: 10 Suppl 11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Coronary Artery Disease; Coronary Vessels; Humans; Hypercholesterolemia; Macrophages; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Receptors, Angiotensin	1999
Cardiac production of angiotensin II and its pharmacologic inhibition: effects on the coronary circulation. Mayo Clinic proceedings, 1999, Volume: 74, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Coronary Circulation; Humans; Myocardial Ischemia; Myocardium; Receptors, Angiotensin	1999
Tissue factor and coronary artery disease. Cardiovascular research, 2002, Feb-01, Volume: 53, Issue:2 Topics: Acute Disease; Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Anticoagulants; Arginine; Aspirin; Coronary Artery Disease; Coronary Thrombosis; Cyclosporine; Endothelium, Vascular; Factor VIIa; Heparin, Low-Molecular-Weight; Hirudin Therapy; Humans; Hypolipidemic Agents; Leukocytes, Mononuclear; Muscle, Smooth, Vascular; Recombinant Proteins; Thrombin; Thromboplastin	2002
Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor. Journal of the American College of Cardiology, 2002, May-01, Volume: 39, Issue:9 Topics: Angiotensin II; Coronary Artery Disease; Diabetes Mellitus; Endothelium, Vascular; Gene Expression; Humans; Myocardial Ischemia; Receptors, LDL; Receptors, Oxidized LDL; Scavenger Receptors, Class E; Tumor Necrosis Factor-alpha; Up-Regulation	2002

Trials

4 trial(s) available for angiotensin ii and Coronary Artery Disease

Article	Year
Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration. Hypertension (Dallas, Tex. : 1979), 2011, Volume: 58, Issue:3 Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Apolipoproteins E; Apoptosis; Benzimidazoles; Benzoates; Blood Vessels; Bone Marrow Transplantation; Cell Count; Cells, Cultured; Coronary Artery Disease; Double-Blind Method; Endothelial Cells; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Ramipril; Receptor, Angiotensin, Type 1; Regeneration; Stem Cells; Telmisartan; Vasoconstrictor Agents	2011
Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease. Circulation, 2005, Feb-08, Volume: 111, Issue:5 Topics: Aged; Angiotensin II; Coronary Artery Disease; Endothelium, Vascular; Exercise; Follow-Up Studies; Humans; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Superoxides; Vasoconstriction; Vasoconstrictor Agents; Vasodilation	2005
Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease. The American journal of cardiology, 2005, Nov-15, Volume: 96, Issue:10 Topics: Aged; Angiotensin II; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Bypass; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; In Vitro Techniques; Male; Mammary Arteries; Middle Aged; Prospective Studies; Pyrroles; Treatment Outcome; Vasodilation	2005
Effect of angiotensin converting enzyme inhibitor on plasma von Willebrand factor level in patients with coronary artery disease. Cardiovascular drugs and therapy, 2001, Volume: 15, Issue:1 Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Enalapril; Female; Humans; Male; Middle Aged; von Willebrand Factor	2001

Other Studies

36 other study(ies) available for angiotensin ii and Coronary Artery Disease

Article	Year
Pleiotropic effects of AT-1 receptor antagonists in hypoxia induced by cardiac ischaemia. Inflammopharmacology, 2022, Volume: 30, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Cells, Cultured; Coronary Artery Disease; Humans; Hypoxia; Inflammation; Ischemia; Myocytes, Cardiac; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1	2022
A knock-in mutation at cysteine 144 of TRIM72 is cardioprotective and reduces myocardial TRIM72 release. Journal of molecular and cellular cardiology, 2019, Volume: 136 Topics: Angiotensin II; Animals; Cardiomegaly; Coronary Artery Disease; Cysteine; Disease Models, Animal; Gene Knock-In Techniques; Insulin Resistance; Membrane Proteins; Mice, Inbred C57BL; Mice, Mutant Strains; Mutation; Myocardial Reperfusion Injury; Myocardium	2019
Aspirin protects human coronary artery endothelial cells by inducing autophagy. Physiology international, 2020, Volume: 107, Issue:2 Topics: Angiotensin II; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Autophagy; Cells, Cultured; Coronary Artery Disease; Coronary Vessels; Endothelial Cells; Humans; Lipoproteins, LDL; Signal Transduction; Vasoconstrictor Agents	2020
Anti-Atherogenic Activity of Polyphenol-Rich Extract from Bee Pollen. Nutrients, 2017, Dec-18, Volume: 9, Issue:12 Topics: Angiotensin II; Animals; Arginine; Atherosclerosis; Bees; Cholesterol; Coronary Artery Disease; Diet, High-Fat; Dose-Response Relationship, Drug; Female; Hypercholesterolemia; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Peptidyl-Dipeptidase A; Pollen; Polyphenols	2017
Epigenetic modulation of tenascin C in the heart: implications on myocardial ischemia, hypertrophy and metabolism. Journal of hypertension, 2019, Volume: 37, Issue:9 Topics: Angiotensin II; Animals; Cardiomegaly; Coronary Artery Disease; DNA Methylation; Energy Metabolism; Epigenesis, Genetic; Extracellular Matrix; Extracellular Matrix Proteins; Fibrosis; Heart Diseases; Humans; Hypertrophy; Hypoxia; Male; Matrix Metalloproteinase 2; MicroRNAs; Myocardial Infarction; Myocardium; Nerve Tissue Proteins; Rats; Tenascin; Ventricular Remodeling	2019
Relationship of renin-angiotensin-aldosterone system polymorphisms and phenotypes to mortality in Chinese coronary atherosclerosis patients. Scientific reports, 2014, Apr-11, Volume: 4 Topics: Aged; Aldosterone; Alleles; Angiotensin II; Asian People; China; Coronary Artery Disease; Female; Follow-Up Studies; Genotype; Humans; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Proportional Hazards Models; Regression Analysis; Renin-Angiotensin System; Risk Factors	2014
Angiotensin II Destabilizes Coronary Plaques in Watanabe Heritable Hyperlipidemic Rabbits. Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:5 Topics: Angiotensin II; Animals; Coronary Artery Disease; Coronary Vessels; Disease Models, Animal; Genetic Predisposition to Disease; Heredity; Hyperlipoproteinemia Type II; Infusion Pumps, Implantable; Infusions, Subcutaneous; Myocardial Infarction; Phenotype; Plaque, Atherosclerotic; Rabbits; Time Factors	2016
Imbalance between angiotensin II and angiotensin-(1-7) in human coronary atherosclerosis. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2016, Volume: 17, Issue:3 Topics: Angiotensin I; Angiotensin II; Atherosclerosis; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Peptide Fragments; Tumor Necrosis Factor-alpha	2016
The water channel AQP1 is expressed in human atherosclerotic vascular lesions and AQP1 deficiency augments angiotensin II-induced atherosclerosis in mice. Acta physiologica (Oxford, England), 2017, Volume: 220, Issue:4 Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Aquaporin 1; Coronary Artery Disease; Female; Humans; Mice; Mice, Knockout; Neovascularization, Pathologic; Vasoconstrictor Agents	2017
Differential mechanisms of angiotensin II and PDGF-BB on migration and proliferation of coronary artery smooth muscle cells. Journal of molecular and cellular cardiology, 2008, Volume: 45, Issue:2 Topics: Angiotensin II; Becaplermin; Cell Line; Cell Movement; Cell Proliferation; Coronary Artery Disease; Coronary Vessels; Humans; Myocytes, Smooth Muscle; Oxidative Stress; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Signal Transduction	2008
A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men. Basic research in cardiology, 2008, Volume: 103, Issue:6 Topics: Adult; Aged; Aldosterone; Alleles; Angiotensin II; Aquaporin 5; Blood Pressure; Case-Control Studies; Cohort Studies; Coronary Artery Disease; Female; Homeostasis; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Renin-Angiotensin System; RNA, Messenger; Sodium Chloride, Dietary	2008
Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration. Circulation research, 2011, Jun-10, Volume: 108, Issue:12 Topics: Angiotensin II; Cell Differentiation; Coronary Artery Disease; Female; Humans; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Receptor, IGF Type 1; Receptor, IGF Type 2; Regeneration; Stem Cell Transplantation; Stem Cells; Transplantation, Autologous	2011
Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation, 2002, Oct-22, Volume: 106, Issue:17 Topics: Angiotensin II; Aortic Valve; Aortic Valve Stenosis; Apolipoproteins B; Coronary Artery Disease; Humans; Immunohistochemistry; Lipoproteins, LDL; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sclerosis	2002
Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arteriosclerosis, thrombosis, and vascular biology, 2002, Nov-01, Volume: 22, Issue:11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Coronary Artery Bypass; Coronary Artery Disease; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Imidazoles; Mammary Arteries; Membrane Glycoproteins; NADH, NADPH Oxidoreductases; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Preoperative Care; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Retrospective Studies; Superoxides; Tetrazoles; Umbilical Veins	2002
Endothelin-1 and vasopressin plasma levels are not associated with the insertion/deletion polymorphism of the human angiotensin I-converting enzyme gene in patients with coronary artery disease. Journal of human hypertension, 2003, Volume: 17, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Coronary Artery Disease; Endothelin-1; Female; Gene Deletion; Humans; Male; Middle Aged; Mutagenesis, Insertional; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Renin; Vasoconstrictor Agents; Vasopressins	2003
Left ventricular size, mass and function in relation to angiotensin-converting enzyme gene and angiotensin-II type 1 receptor gene polymorphisms in patients with coronary artery disease. Clinical chemistry and laboratory medicine, 2003, Volume: 41, Issue:4 Topics: Angiotensin II; Coronary Artery Disease; DNA; DNA Primers; Echocardiography; Female; Gene Deletion; Genotype; Homozygote; Humans; Male; Middle Aged; Myocardial Infarction; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Ventricular Function, Left; White People	2003
Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury. Circulation, 2003, Nov-18, Volume: 108, Issue:20 Topics: Aldosterone; Angiotensin II; Animals; Cardiovascular Diseases; Coronary Artery Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mineralocorticoid Receptor Antagonists; Myocardium; NG-Nitroarginine Methyl Ester; Plasminogen Activator Inhibitor 1; Proteinuria; Sodium, Dietary; Spironolactone	2003
Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells. Journal of molecular and cellular cardiology, 2004, Volume: 37, Issue:2 Topics: Angiotensin II; Coronary Artery Disease; Coronary Vessels; Gene Expression; Humans; Inflammation Mediators; Interleukin-1; Intracellular Signaling Peptides and Proteins; Muscle, Smooth, Vascular; Myocardium; NF-kappa B; Protein Kinase C; Protein Serine-Threonine Kinases; rho-Associated Kinases; RNA, Messenger; Tetradecanoylphorbol Acetate; Up-Regulation	2004
Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 44, Issue:3 Topics: Angiotensin II; Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Coronary Artery Disease; Fibrosis; Hypercholesterolemia; Hypertension, Renovascular; Ligation; Mice; Mice, Knockout; Nephrectomy; Renal Artery; Renin; Renin-Angiotensin System; Rupture, Spontaneous; Th1 Cells; Th2 Cells; Vasculitis	2004
[Study on relationship between the polymorphism of angiotensin converting enzyme gene and blood stasis syndrome in patients with coronary heart disease]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2004, Volume: 24, Issue:9 Topics: Aged; Alleles; Angina Pectoris; Angiotensin II; Coronary Artery Disease; Diagnosis, Differential; Endothelins; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Nitric Oxide; Peptidyl-Dipeptidase A; Polymorphism, Genetic	2004
Vascular response to angiotensin II predicts long-term prognosis in patients undergoing coronary artery bypass grafting. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 44, Issue:6 Topics: Aged; Angiotensin II; Blood Pressure; Coronary Artery Bypass; Coronary Artery Disease; Female; Follow-Up Studies; Humans; In Vitro Techniques; Male; Middle Aged; Peptidyl-Dipeptidase A; Prognosis; Proportional Hazards Models; Renin-Angiotensin System; Risk Factors; Survival Analysis; Thoracic Arteries; Vasoconstrictor Agents	2004
Angiotensin II induces MMP-2 in a p47phox-dependent manner. Biochemical and biophysical research communications, 2005, Mar-04, Volume: 328, Issue:1 Topics: Angiotensin II; Animals; Cardiomyopathies; Cells, Cultured; Coronary Artery Disease; Coronary Vessels; Dose-Response Relationship, Radiation; Humans; In Vitro Techniques; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Myocytes, Smooth Muscle; NADPH Oxidases; Phosphoproteins	2005
[Prevention of cardiovascular events in the era of drug eluting stents (DES) and angiotension II receptor blockers (ARB)]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Coronary Artery Disease; Coronary Restenosis; Stents	2005
Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2: implications for atherosclerotic plaque rupture. Journal of leukocyte biology, 2005, Volume: 78, Issue:1 Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Cells, Cultured; Coronary Artery Disease; Dinoprostone; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hypertension; Imidazoles; Matrix Metalloproteinase 1; Monocytes; Myocardial Infarction; Oligopeptides; Phosphoprotein Phosphatases; Pyridines; Receptor, Angiotensin, Type 2; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation	2005
Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension. Microvascular research, 2005, Volume: 70, Issue:3 Topics: Administration, Oral; Age Factors; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Benzimidazoles; Benzoates; Blotting, Western; Coronary Artery Disease; Disease Progression; DNA Primers; Endothelial Cells; Endothelium, Vascular; Female; Humans; Hypertension; Male; Microcirculation; Middle Aged; Oxidative Stress; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Telmisartan; Time Factors; Up-Regulation	2005
Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:2 Topics: Adult; Angiotensin II; Coronary Artery Disease; Coronary Vessels; Female; Humans; Male; Membrane Transport Proteins; Middle Aged; NADPH Oxidases; Oxidative Stress; Phosphoproteins; Protein Kinase C; Superoxides; Vasoconstrictor Agents; Xanthine Oxidase	2006
Clinical pathology and treatment of renin-angiotensin system 3. Atherosclerosis and the renin-angiotensin system. Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:16 Topics: Angiotensin II; Animals; Atherosclerosis; Coronary Artery Disease; Endothelium, Vascular; Mice; Oxidative Stress; Receptors, Angiotensin; Renin-Angiotensin System	2007
Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery disease. Journal of cardiovascular pharmacology, 2007, Volume: 50, Issue:4 Topics: Acetylcholine; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Coronary Artery Disease; Female; Gene Expression; Humans; Imidazoles; In Vitro Techniques; Male; Mammary Arteries; Middle Aged; Oligopeptides; Phentolamine; Phenylephrine; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium Nitrite; Tetrazoles; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents	2007
Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation, 1996, Dec-01, Volume: 94, Issue:11 Topics: Adolescent; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cell Aggregation; Cell Line; Cholesterol, LDL; Coronary Artery Disease; Coronary Vessels; Female; Humans; Immunohistochemistry; Macrophages; Male; Middle Aged; Peptidyl-Dipeptidase A; T-Lymphocytes; Tetradecanoylphorbol Acetate; Tissue Distribution	1996
Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. The American journal of cardiology, 1999, Apr-15, Volume: 83, Issue:8 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Coronary Artery Disease; Disease Progression; Humans; Rats; Treatment Outcome	1999
Relative localization of angiotensin-converting enzyme, chymase and angiotensin II in human coronary atherosclerotic lesions. Journal of hypertension, 1999, Volume: 17, Issue:4 Topics: Adolescent; Adult; Aged; Angiotensin II; Autopsy; Child; Chymases; Coronary Artery Disease; Coronary Vessels; Female; Humans; Immunohistochemistry; Male; Middle Aged; Peptidyl-Dipeptidase A; Serine Endopeptidases	1999
Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein. Circulation, 1999, Aug-31, Volume: 100, Issue:9 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Cells, Cultured; Coronary Artery Bypass; Coronary Artery Disease; Down-Regulation; Endothelium, Vascular; Humans; Losartan; Mammary Arteries; Receptors, LDL; Receptors, Oxidized LDL; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Scavenger Receptors, Class E; Umbilical Veins	1999
Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation, 2000, Mar-28, Volume: 101, Issue:12 Topics: Angina, Unstable; Angiotensin II; Animals; Coronary Artery Disease; Coronary Vessels; Humans; Immunohistochemistry; Interleukin-6; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System	2000
Modulation of sympathetic coronary vasoconstriction by cardiac renin-angiotensin system in human coronary heart disease. Circulation, 2000, May-16, Volume: 101, Issue:19 Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteries; Benzazepines; Blood Pressure; Cold Temperature; Coronary Artery Disease; Coronary Vessels; Diving; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption; Renin-Angiotensin System; Sodium Chloride; Sympathetic Nervous System; Vasoconstriction	2000
Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor. Kidney international, 2000, Volume: 58, Issue:2 Topics: Angiotensin II; Animals; Aorta, Thoracic; Cell Division; Cells, Cultured; Coronary Artery Disease; DNA; Enzyme Activation; ErbB Receptors; Hypertension, Renal; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; src-Family Kinases; Vasoconstrictor Agents	2000
Use of angiotensin-converting enzyme inhibitors in patients with diabetes and coronary artery disease. Current problems in cardiology, 2002, Volume: 27, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bradykinin; Chymases; Coronary Artery Disease; Diabetic Angiopathies; Endothelium, Vascular; Fibrinolysis; Humans; Losartan; Oxidative Stress; Serine Endopeptidases	2002